• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Immucor, Inc.

NASDAQ:BLUD

$26.81 $0.00 (0.00%)

Quote as of

Analyst Research on Celldex Therapeutics Inc. and Immucor Inc. - Diagnostic Substances Hurt by Macro Economy

IVD Acquisition Corporation completes acquisition of Immucor

Immucor announces end of "Go-Shop" period, no proposals submitted

Immucor Announces End of "Go-Shop" Period

Valassis to be added to S&P 400; Immucor deleted as of 8/18 close

Standard & Poor's Announces Change to U.S. Index

Immucor, IVD Acquisition announce German antitrust/merger control clearance

Immucor and IVD Acquisition Corporation Announce German Antitrust and Merger Control Clearance

Immucor and IVD Acquisition announce expiration of HSR waiting period

Immucor and IVD Acquisition Corporation Announce Expiration of HSR Waiting Period

Equity Research on Immucor Inc. and Celldex Therapeutics Inc. - Uncertainty for Diagnostic Substances Sector

Immucor reveals fifth class action suit challenging IVD Acquisition tender offer

The Law Firm of Levi & Korsinsky, LLP Notifies Shareholders of Claims of Breaches of Fiduciary Duty Against the Board of Immucor, Inc. in Connection With Takeover by TPG Capital

The Law Firm of Levi & Korsinsky, LLP Notifies Shareholders of Claims of Breaches of Fiduciary Duty Against the Board of Immucor, Inc. in Connection With Takeover by TPG Capital

Immucor Inc. Reports Operating Results (10-K)

Haemonetics May Be Warning You. Are You Listening?

Here's Why Qiagen NV's Latest Report Might Worry You

IVD commences tender offer for all shares of Immucor

IVD Acquisition Corporation Commences Tender Offer for All Shares of Immucor, Inc.

The Law Office of Abe Shainberg Announces Investigation of Immucor, Inc.

Immucor downgraded to Neutral from Outperform at RW Baird

The Law Firm of Weiss & Lurie Investigates Immucor, Inc.

Is Cerus the Perfect Stock?

Immucor downgraded to Neutral from Positive at Susquehanna

Immucor Inc.

Harwood Feffer LLP Announces Investigation of Immucor, Inc.

Immucor, Inc. Shareholder Alert -- The Briscoe Law Firm Investigates Immucor, Inc. for Shareholders Concerning the Acquisition by TPG Capital

Value Investor Arnold Van Den Berg Is Finding Plenty of Ideas; Buys BRK. ...

Earnings Season Could Bring Clarity to Markets (NTCT, BLUD, AMN, NOV, JOE, EXK, IMAX)

Nasdaq Extends Gains

Faruqi & Faruqi, LLP Announces Investigation of Immucor, Inc.

Bernstein Liebhard LLP Announces Investigation of Immucor, Inc.

Tuesday’s Stocks to Watch: Immucor, Advanced Energy

Pre-market Movers For July 5 (MSFT, BIDU, ZLCS, BLUD, SUG, ZN, ALLT, TGA, AIXG)

Top Active Trader Alert Stocks (BIDU, BLUD, CLWR)

Equity Research on Immucor Inc. and Celldex Therapeutics Inc. - New Drugs in the Pipeline Bring Positive Outlook

Is Gen-Probe Going to Burn You?

Are the Earnings at Qiagen Hiding Something?

Immucor CEO, Dr. Gioacchino De Chirico, announces retirement

Immucor CEO Dr. Gioacchino De Chirico Announces Retirement; Board Appoints Joshua H. Levine CEO and Director

See More Articles...